It was originally developed for type 2 diabetes management (Ozempic) but showed such dramatic weight loss effects that the FDA approved a higher-dose formulation for chronic weight management (Wegovy)
today, more than half (27) grant them that freedom under state law (called scope of practice laws)
For health technology assessment (HTA) and payer teams, the access question will likely focus on the credibility of systolic blood pressure as the decision-relevant endpoint, the positioning of the drug after multi-drug background therapy, and the monitoring requirements for potassium and sodium
Contact your healthcare provider for anxiety symptoms lasting more than two weeks, progressively worsening anxiety, or symptoms interfering with daily functioning
Learn the difference between compounded GLP-1s and Brand Name GLP-1s, and which is better for women in menopause
Al combinarlo con un programa regular de ejercicio, sentimos que los resultados fueron ms evidentes: no solo logramos mantenernos activos por ms tiempo, sino que tambin observamos cambios positivos en la composicin corporal
